These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2658787)
1. Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391. Satake S; Hiraoka M; Mitsuhashi S Antimicrob Agents Chemother; 1989 Mar; 33(3):398-9. PubMed ID: 2658787 [TBL] [Abstract][Full Text] [Related]
2. Interaction of E1040 with cephalosporinase from Citrobacter freundii GN7391. Inoue E; Mitsuhashi S Antimicrob Agents Chemother; 1989 Dec; 33(12):2157-9. PubMed ID: 2694954 [TBL] [Abstract][Full Text] [Related]
3. Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime. Hiraoka M; Masuyoshi S; Mitsuhashi S; Tomatsu K; Inoue M J Antibiot (Tokyo); 1988 Jan; 41(1):86-93. PubMed ID: 3279015 [TBL] [Abstract][Full Text] [Related]
4. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins. Hiraoka M; Inoue M; Mitsuhashi S Rev Infect Dis; 1988; 10(4):746-51. PubMed ID: 3055173 [TBL] [Abstract][Full Text] [Related]
5. Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase. Tsukamoto K; Ohno R; Sawai T J Bacteriol; 1990 Aug; 172(8):4348-51. PubMed ID: 2115867 [TBL] [Abstract][Full Text] [Related]
6. Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum. Kobayashi S; Arai S; Hayashi S; Fujimoto K Antimicrob Agents Chemother; 1986 Nov; 30(5):713-8. PubMed ID: 3492175 [TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activities of FK037: a new parenteral cephalosporin. Inoue K; Inoue E; Mitsuhashi S Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206 [TBL] [Abstract][Full Text] [Related]
8. Affinity of cefmenoxime for beta-lactamases: an analysis. Labia R; Morand A; Verchere-Beaur C; Bryskier A Am J Med; 1984 Dec; 77(6A):25-7. PubMed ID: 6097119 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome. Mitsukude M; Inoue M; Mitsuhashi S Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801 [TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity and beta-lactamase stability of E-0702, a new cephalosporin. Neu HC; Labthavikul P Antimicrob Agents Chemother; 1983 Sep; 24(3):313-20. PubMed ID: 6605718 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of inhibition of chromosomal beta-lactamases by third-generation cephalosporins. Charnas RL; Then RL Rev Infect Dis; 1988; 10(4):752-60. PubMed ID: 3142012 [TBL] [Abstract][Full Text] [Related]
12. The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime. Fu KP; Neu HC J Antibiot (Tokyo); 1979 Sep; 32(9):909-14. PubMed ID: 315938 [TBL] [Abstract][Full Text] [Related]
13. Substitution of aspartic acid-217 of Citrobacter freundii cephalosporinase and properties of the mutant enzymes. Tsukamoto K; Kikura R; Ohno R; Sawai T FEBS Lett; 1990 May; 264(2):211-4. PubMed ID: 1972682 [TBL] [Abstract][Full Text] [Related]
18. Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391. Tajima M; Takenouchi Y; Sugawara S; Inoue M; Mitsuhashi S J Gen Microbiol; 1980 Dec; 121(2):449-56. PubMed ID: 6973612 [TBL] [Abstract][Full Text] [Related]
19. Influence of methoxy-substitution of beta-lactam compounds on the interaction with various beta-lactamases. Cullmann W; Dick W Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):109-18. PubMed ID: 6362278 [TBL] [Abstract][Full Text] [Related]
20. Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents. Nikaido H; Liu W; Rosenberg EY Antimicrob Agents Chemother; 1990 Feb; 34(2):337-42. PubMed ID: 2109581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]